CANDELA INVEST (CAND.BR) Fundamental Analysis & Valuation

EBR:CAND • BE0974298300

Current stock price

2.4 EUR
+0.2 (+9.09%)
Last:

This CAND.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CAND.BR Profitability Analysis

1.1 Basic Checks

  • In the past year CAND has reported negative net income.
  • In multiple years CAND reported negative net income over the last 5 years.
  • In the past 5 years CAND always reported negative operating cash flow.
CAND.BR Yearly Net Income VS EBIT VS OCF VS FCFCAND.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 0 500K -500K 1M -1M

1.2 Ratios

  • With a Return On Assets value of -8.85%, CAND is not doing good in the industry: 69.17% of the companies in the same industry are doing better.
  • CAND has a Return On Equity of -32.90%. This is in the lower half of the industry: CAND underperforms 69.17% of its industry peers.
Industry RankSector Rank
ROA -8.85%
ROE -32.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAND.BR Yearly ROA, ROE, ROICCAND.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2023 2024 0 -20 -40

1.3 Margins

  • CAND does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAND.BR Yearly Profit, Operating, Gross MarginsCAND.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CAND.BR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CAND remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CAND has more shares outstanding
  • CAND has a worse debt/assets ratio than last year.
CAND.BR Yearly Shares OutstandingCAND.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 200K 400K 600K 800K 1M
CAND.BR Yearly Total Debt VS Total AssetsCAND.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M

2.2 Solvency

  • CAND has an Altman-Z score of 1.38. This is a bad value and indicates that CAND is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CAND (1.38) is better than 63.33% of its industry peers.
  • CAND has a Debt/Equity ratio of 2.17. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 2.17, CAND perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Altman-Z 1.38
ROIC/WACCN/A
WACCN/A
CAND.BR Yearly LT Debt VS Equity VS FCFCAND.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M

2.3 Liquidity

  • A Current Ratio of 5.31 indicates that CAND has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 5.31, CAND belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
  • CAND has a Quick Ratio of 4.82. This indicates that CAND is financially healthy and has no problem in meeting its short term obligations.
  • CAND has a better Quick ratio (4.82) than 90.83% of its industry peers.
Industry RankSector Rank
Current Ratio 5.31
Quick Ratio 4.82
CAND.BR Yearly Current Assets VS Current LiabilitesCAND.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. CAND.BR Growth Analysis

3.1 Past

  • The earnings per share for CAND have decreased strongly by -449.40% in the last year.
  • CAND shows a small growth in Revenue. In the last year, the Revenue has grown by 1.99%.
  • The Revenue has been decreasing by -6.33% on average over the past years.
EPS 1Y (TTM)-449.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.42%
Revenue 1Y (TTM)1.99%
Revenue growth 3Y-4.31%
Revenue growth 5Y-6.33%
Sales Q2Q%22.2%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CAND.BR Yearly Revenue VS EstimatesCAND.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. CAND.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • CAND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CAND.BR Price Earnings VS Forward Price EarningsCAND.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAND.BR Per share dataCAND.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAND.BR Dividend Analysis

5.1 Amount

  • CAND does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAND.BR Fundamentals: All Metrics, Ratios and Statistics

CANDELA INVEST

EBR:CAND (3/23/2026, 7:00:00 PM)

2.4

+0.2 (+9.09%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.59M
Revenue(TTM)7.99M
Net Income(TTM)-756.70K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.32
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-0.7
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS7.4
BVpS2.14
TBVpS2.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.85%
ROE -32.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 2.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.31
Quick Ratio 4.82
Altman-Z 1.38
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-449.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.42%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1.99%
Revenue growth 3Y-4.31%
Revenue growth 5Y-6.33%
Sales Q2Q%22.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-963.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CANDELA INVEST / CAND.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CANDELA INVEST (CAND.BR) stock?

ChartMill assigns a fundamental rating of 1 / 10 to CAND.BR.


Can you provide the valuation status for CANDELA INVEST?

ChartMill assigns a valuation rating of 0 / 10 to CANDELA INVEST (CAND.BR). This can be considered as Overvalued.


What is the profitability of CAND stock?

CANDELA INVEST (CAND.BR) has a profitability rating of 0 / 10.


What is the financial health of CANDELA INVEST (CAND.BR) stock?

The financial health rating of CANDELA INVEST (CAND.BR) is 4 / 10.